Accueil>>Analytical Standards>>Linoleoyl Ethanolamide-d4

Linoleoyl Ethanolamide-d4 (Synonyms: LEA-d4)

Catalog No.GC47568

An internal standard for the quantification of linoleoyl ethanolamide

Products are for research use only. Not for human use. We do not sell to patients.

Linoleoyl Ethanolamide-d4 Chemical Structure

Cas No.: 1451194-69-6

Taille Prix Stock Qté
100 μg
43,00 $US
En stock
500 μg
194,00 $US
En stock
1 mg
342,00 $US
En stock
5 mg
1 499,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Linoleoyl ethanolamide-d4 contains four deuterium atoms at the hydroxyethyl 1,1',2, and 2' positions. It is intended for use as an internal standard for the quantification of linoleoyl ethanolamide by GC- or LC-mass spectrometry. Linoleoyl ethanolamide is an endocannabinoid detected in porcine brain and murine peritoneal macrophages which contains linoleate in place of the arachidonate moiety of arachidonoyl ethanolamide (AEA).1,2 It has weak affinity for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, exhibiting Ki values of 10 µM and 25 µM, respectively.3 However, it is only approximately 4-fold less potent than AEA at causing catalepsy in mice (ED50 of 26.5 mg/kg).4 In addition, linoleoyl ethanolamide increases ERK phosphorylation and AP-1-dependent transcription approximately 1.5-fold at 15 µM in a CB-receptor-independent manner.5 However, cellular toxicity is readily apparent at concentrations of 10-20 µM. Linoleoyl ethanolamide inhibits human fatty acid amide hydrolase-dependent hydrolysis of AEA with a Ki value of 9.0 µM, but also is hydrolyzed effectively by the enzyme.6,7

1.Patrono, C., Rotella, C.M., Toccafondi, R.S., et al.Prostacyclin stimulates the adenylate cyclase system of human thyroid tissueProstaglandins22(1)105-115(1981) 2.Schmid, P.C., Kuwae, T., Krebsbach, R.J., et al.Anandanide and other N-acylethanolamines in mouse peritoneal macrophagesChemistry and Physics of Lipids87103-110(1997) 3.Lin, S., Khanolkar, A.D., Fan, P., et al.Novel analogues of arachidonylethanolamide (anandamide): Affinities for the CB1 and CB2 cannabinoid receptors and metabolic stabilityJournal of Medicinal Chemistry415353-5361(1998) 4.Watanabe, K., Matsunaga, T., Nakamura, S., et al.Pharmacological effects in mice of anandamide and its related fatty acid ethanolamides, and enhancement of cataleptogenic effect of anandamide by phenylmethylsulfonyl fluorideBiological and Pharmaceutical Bullentin22(4)366-370(1999) 5.Berdyshev, E.V., Schmid, P.C., Krebsbach, R.J., et al.Cannabinoid-receptor-independent cell signalling by N-acylethanolaminesBiochemistry Journal36067-75(2001) 6.Maccarrone, M., van der Stelt, M., Rossi, A., et al.Anandamide hydrolysis by human cells in culture and brainThe Journal of Biological Chemisty27332332-32339(1998) 7.Bisogno, T., Maurelli, S., Melck, D., et al.Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytesThe Journal of Biological Chemisty2723315-3323(1997)

Avis

Review for Linoleoyl Ethanolamide-d4

Average Rating: 5 ★★★★★ (Based on Reviews and 37 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Linoleoyl Ethanolamide-d4

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.